机译:伊立替康HCI对人早幼粒细胞白血病HL-60细胞凋亡死亡的抗肿瘤作用及对白血病异种移植肿瘤生长的抑制作用
Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu 300, Taiwan;
School of Pharmacy, China Medical University, Taichung 404, Taiwan;
Department of Pharmacology, China Medical University, Taichung 404, Taiwan;
Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 112, Taiwan;
Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan;
Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan;
Department of Restaurant, Hotel and Institutional Management, Fu-Jen Catholic University, New Taipei 242, Taiwan;
Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 112, Taiwan,Department of Restaurant, Hotel and Institutional Management, Fu-Jen Catholic University, New Taipei 242, Taiwan;
Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan,Department of Biotechnology, Asia University, Taichung 413, Taiwan;
irinotecan HCI; antileukemia; apoptosis; in vitro; tumor xenograft model;
机译:源自坦普尼约的葡萄籽提取物诱导人早幼粒细胞白血病HL-60细胞凋亡和死亡
机译:3,3',4,4',5,5'-六羟基sti在HL-60人早幼粒细胞白血病细胞中的抗肿瘤作用。
机译:一种新型的含吡普拉汀衍生物的铂配合物,在人急性早幼粒细胞白血病HL-60细胞中具有增强的细胞毒性,引起氧化应激并通过ERK / p38途径触发凋亡性细胞死亡。
机译:RNS激活人类髓样白血病细胞凋亡性细胞死亡:使用抵抗性屏障血浆的新型抗肿瘤方法
机译:声激活蒽环类药物从普鲁尼克P105胶束向人白血病(HL-60)细胞的递送。
机译:一种新型的含吡普拉汀衍生物的铂配合物在人急性早幼粒细胞白血病HL-60细胞中具有增强的细胞毒性引起氧化应激并通过ERK / p38途径触发凋亡性细胞死亡。
机译:通过人早幼粒细胞白血病HL-60细胞中核糖核苷酸和脱氧核糖核苷酸的代谢扰动探讨大剂量阿糖胞苷的抗肿瘤机制
机译:表达s-腺苷-L-甲硫氨酸与HL-60早幼粒细胞白血病细胞质膜的结合。 (重新公布新的可用性信息)。